GMED — Globus Medical, Inc.
GMED dilution and offerings
- Float: 131.1M shares
$79.46+1.81%
Last close: · regular session
Last 60 sessions
Float: 131.1M shares. Latest SEC filing: 10-Q on May 7, 2026. GMED closed at $79.46 (+1.81%) on Nov 2, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for GMED in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NYSE
- Employees: 5,300
- Website: https://www.globusmedical.com
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Latest SEC filings for GMED
Latest GMED news
- GMED vs. AXGN: Which Stock Should Value Investors Buy Now? Read article
- Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet Read article
- Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term Read article
- GMED or AXGN: Which Is the Better Value Stock Right Now? Read article
- Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026 Read article
- Globus Medical Schedules Third Quarter Earnings Release and Conference Call Read article
- Reasons to Add Globus Medical Stock to Your Portfolio Now Read article
- Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.